Are we entering a world in which all of the exciting new therapeutics come from China? At #JPM25, that question and ...
One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback